everyone only too happy now to pin their hopes on a sample of one.
One patient.
The P2a 200mg group was a bit larger, and even that group was too small to say anything about.
Sure, one patient, anecdotal info, may have done better, and that is great.
I hope P is a winner.
We will all finally find out if a couple of months.
Maybe then we will be told there will be another group, and another trial, for 600mg.......